SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Street who wrote (323)9/19/1998 9:03:00 PM
From: Bleeker  Read Replies (1) of 857
 
True, outside the 97,500 the others are planned sales. But once
you file a 144 (intent to sell) I don't think you need to file
again. Someone may want to confirm this with Edgar because I'm
not 100% sure.

Did you know that once the options and warrants are exercised
the number of outstanding shares will increase by twofold,
setting the stage for a serious dilution. Is this a common
tactic that management uses to beef up salaries without raising
eyebrows? If so it's very misleading because in addition to the
dilution it creates tremendous selling pressure as these warrants
and options are exercised.

Does any one know when the warrants and options will be open
for exercise?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News